ArticleCancers2025

Capacity for Compensatory Cyclin D2 Response Confers Trametinib Resistance in Canine Mucosal Melanoma.

Bih-Rong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.